See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI102.40▲ 2.95%
← ZCRM page
XStocksXray
Market X-Ray report · 15 October 2026

Salesforce, Inc. (ZCRM)

NEO Exchange · Canada · prices in CAD · close of 15 Oct 2026

Key indicators

Last closeCAD 10.28
52-week range6.32 – 11.27
Return, 1 month / 3 months−3.7% / +46.4%
Return, 1 year / 3 years– / –
TrendUptrend
RSI (14)60
Volatility (1 year)53.4%
Worst drawdown (1 year)-43.9%
Average daily value traded0.00M CAD
Dividend yield–

Market X-Ray price-based

59/ 100 · Medium confidence · ahead of 65% of stocks on this exchange
Trend84
Momentum94
Stability (higher is calmer)31
Liquidity3
Income–

Five-year price chart navy: price · brown: 200-day average

6.027.418.8010.1811.572025-102026-012026-042026-072026-10

About the company

Salesforce, Inc. provides cloud-based software that helps businesses manage their relationships with customers. Its main offering is a customer relationship management platform, alongside applications for sales, customer service, marketing, commerce and analytics. Organisations of many kinds use these subscription services to track contacts, handle support requests and run marketing campaigns. The company is based in San Francisco, California, and serves customers around the world through its online software platform.

On this site Salesforce, Inc. appears as a stock on the NEO Exchange (Canada), code ZCRM, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Salesforce, Inc. (ZCRM) trades on the NEO Exchange in Canada. It last closed at CAD 10.28 on 15 October 2026.

Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 57 of 163 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Salesforce, Inc. (ZCRM)

The five lenses in numbers each metric is ranked against the other stocks on NEO Exchange

Lens and metricValueScoreReading
Trend84 · StrongTrading above its long-term averages and near its highs.
Above 200-day average22.1%
From 52-week high-8.8%
Momentum94 · StrongRising faster than most stocks on this exchange.
3-month return46.4%
6-month return37.1%
12-month return, skipping the last month–
Stability (higher is calmer)31 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)53.4%
Worst drawdown, 1 year (smaller is calmer)-43.9%
Liquidity3 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.00M CAD
Zero-volume days60.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+9.2%
1 month−3.7%
3 months+46.4%
6 months+37.1%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average9.55 / 8.42
Golden / death cross (60 days)Golden, 20 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.21

Technical summary

DailyStrongly bullish11 bullish · 1 neutral · 3 bearish
WeeklyStrongly bullish7 bullish · 1 neutral · 0 bearish
MonthlyNeutral1 bullish · 0 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on NEO Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026